RASOULI M, LEHNER R. ANTICALMODULIN DRUGS DUE TO THE NET EFFECTS CANNOT ANTAGONIZE DIBUTYRYL-CAMP-MEDIATED SUPPRESSION OF DE NOVO SYNTHESIZED LIPID SECRETION IN BOTH CULTURED MCARDLE CELLS AND RAT HEPATOCYTES. Med J Islam Repub Iran 2004; 18 (1) :45-53
URL:
http://mjiri.iums.ac.ir/article-1-654-en.html
University of Sari , mehdi2rasouli@yahoo.com.
Abstract: (4042 Views)
The effects and interaction between cAMP-analogue dibutyryl-cAMP and
calmodulin antagonists were investigated on de novo synthesis and secretion of lipids in
cultures of hepatoma McArdle-RH7777 cells and normal rat hepatocytes. Dibutyryl cAMP caused a significant decrease in the secretion of de novo synthesized
triacyl [3H] glycerol in both cultures of McArdle cells and rat hepatocytes. The inhibitory
effect of dibutyryl-cAMP was concentration-dependent and appeared at the lowest
concentration examined, 5 µM. Dibutyryl-cAMP at a concentration of 50 11M suppressed
secretion of triacylglycerol by approximately 38% (p<0.05) and secretion of
phosphatidylcholine by 30% (p<0.05). Dibutyryl-cAMP did not affect the synthesis of
triacylglycerol and phosphatidylcholine, except at the highest concentration tested,
500 µM, where both triacylgJycerol and phosphatidylcholine synthesis were suppressed significantly.
Anticalmodulin W-7 also inhibited secretion of newly made triacylglycerol in a
concentration-dependent manner in both cultures of McArdle cells and rat hepatocytes.
W-7 at a concentration of 20 µM suppressed triacylglycerol secretion by about
37% (p<0.05), while the secretion of phosphatidylcholine and synthesis o f
triacylglycerol and phosphatidylcholine were not affected, unless at more than 20
µM concentration, at which both triacylglycerol and phosphatidylcholine synthesis were
decreased significantly.
The inhibitory effect elicited by dibutylyl-cAMP (100 µM) was not abolished in
the presence of calmodulin antagonists, W-7 (20 µM), trifluo perazine (20 µM) and
chlorpromazine (20 µM). The simultaneous effects of dibutyryl-cAMP and e ither
calmodulin antagonists were not additive or synergistic. None of the calmodulin antagonists
affected the cellular content of de novo synthesized triacylglycerol and p hosphatidy1choline
significantly. Neither dibutyryl-cAMP nor any calmodulin antagonist or
their combination did affect the overall rate of de novo synthesis of triacylglycerol and
phosphatidylcholine. All calmodulin antagonists examined alone also had a net significant
inhibitory effect on the secretion of newly made triacylglycerol. The results presented
here suggest that calmodulin antagonists have net direct effects and hence could
not overcome dibutyryl-cAMP-induced suppressive effects on the secretion of newly
made triacylglycerol. The cell types, normal hepatocytes relative to hepatomas, did not
influence the results.